Pyrimidine-based Chemistry in Trypanosoma brucei Drug Discovery: Molecular Targets, Structure-Activity Relationships, and Emerging Perspectives for Sustainable Therapeutics
RSC Medicinal Chemistry · 2026
DOI: 10.1039/d6md00908e ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2026. Verfasst von Valeria Francesconi und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Human African trypanosomiasis (HAT), caused by Trypanosoma brucei (T. brucei), remains a neglected tropical disease and a significant public health burden in endemic regions of sub-Saharan Africa. Although considerable progress...
Zitieren
APA
Francesconi, V., Zheng, D. D., Carbone, A., Schenone, S., & Tonelli, M. (2026). Pyrimidine-based Chemistry in Trypanosoma brucei Drug Discovery: Molecular Targets, Structure-Activity Relationships, and Emerging Perspectives for Sustainable Therapeutics. RSC Medicinal Chemistry. https://doi.org/10.1039/d6md00908e
Vancouver
Francesconi V, Zheng DD, Carbone A, Schenone S, Tonelli M. Pyrimidine-based Chemistry in Trypanosoma brucei Drug Discovery: Molecular Targets, Structure-Activity Relationships, and Emerging Perspectives for Sustainable Therapeutics. RSC Medicinal Chemistry. 2026. doi:10.1039/d6md00908e
BibTeX
@article{Francesconi2026,
author = {Francesconi, Valeria and Zheng, Deyi Davide and Carbone, Anna and Schenone, Silvia and Tonelli, Michele},
title = {Pyrimidine-based Chemistry in Trypanosoma brucei Drug Discovery: Molecular Targets, Structure-Activity Relationships, and Emerging Perspectives for Sustainable Therapeutics},
journal = {RSC Medicinal Chemistry},
year = {2026},
doi = {10.1039/d6md00908e}
}
EUVIMED